Sector revisions Photocure ASA

Stocks

Market Closed - Oslo Bors 10:45:00 2026-09-21 EDT			5-day change	1st Jan Change
52.80 ^NOK	+2.13%		+1.73%	-26.05%

08-16	Photocure Sees Potential in US FDA's Proposed Reclassification of Cystoscopy Systems	MT
08-14	Photocure ASA Initiates FDA Proposal To Reclassify Blue Light Cystoscopy Systems From Class III To Class II	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	1y. EPS revision	Nbr of analysts
PHOTOCURE ASA			3
ELI LILLY AND COMPANY			29
JOHNSON & JOHNSON			22
ABBVIE INC.			28
ROCHE HOLDING AG			19
NOVARTIS AG			22
ASTRAZENECA PLC			23
AMGEN INC.			29
NOVO NORDISK A/S			23
GILEAD SCIENCES, INC.			27
PFIZER INC.			26
VERTEX PHARMACEUTICALS INCORPORATED			27
BRISTOL-MYERS SQUIBB COMPANY			24
SANOFI			24
GSK PLC			21
CHUGAI PHARMACEUTICAL CO., LTD.			15
TAKEDA PHARMACEUTICAL COMPANY LIMITED			16
BAYER AG			18
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	-	-	1
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD			17
Average			21
Weighted average by Cap.			24